Delic Survey Shows Americans With Mental Health Conditions Are Ready For Access To Psychedelics Jan 20, 2022
Revitalist Provides Summary of 2021, Reporting Patient Visits of 5,000, a 128% Increase From 2020 Jan 20, 2022
Numinus Announces Key Milestones in MAPS-Sponsored MDMA-Assisted Therapy for PTSD Clinical Trial Jan 19, 2022
Two Thirds Of Physicians Surveyed Believe Psilocybin Therapy Has Potential Benefit For Patients With Treatment-Resistant… Jan 19, 2022
Mydecine Signs LOI with The Newly Institute to Provide Psychedelic-Assisted Psychotherapy to Patients under Health… Jan 18, 2022
How Significant Are Recent Changes To Psychedelics Access In Canada? ‘It Can’t Be Understated’ Says Numinus CEO Jan 12, 2022
Mydecine Achieves Innovative Supercomputing Artificial Intelligence Modeling in Psychedelic Drug Development Enabling… Jan 10, 2022
Field Trip Announces Intention to Make Applications on Behalf of Patients to Health Canada’s Special Access Program… Jan 6, 2022
